International Biotechnology (LON:IBT) Insider Purchases £10,695 in Stock

International Biotechnology (LON:IBT) insider Katherine Cornish-Bowden bought 1,500 shares of the company’s stock in a transaction dated Tuesday, December 17th. The stock was bought at an average cost of GBX 713 ($9.05) per share, for a total transaction of £10,695 ($13,568.89).

International Biotechnology Stock Performance

LON:IBT traded down GBX 15 ($0.19) during midday trading on Tuesday, reaching GBX 698 ($8.86). The stock had a trading volume of 58,452 shares, compared to its average volume of 69,127. The stock has a market cap of £257.98 million, a P/E ratio of 1,466.18 and a beta of 0.21. The company has a quick ratio of 0.32, a current ratio of 0.46 and a debt-to-equity ratio of 9.66. International Biotechnology has a 12-month low of GBX 588 ($7.46) and a 12-month high of GBX 734 ($9.31). The firm has a fifty day simple moving average of GBX 694.15 and a two-hundred day simple moving average of GBX 677.59.

International Biotechnology Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, January 24th. Shareholders of record on Thursday, December 19th will be given a dividend of GBX 15.56 ($0.20) per share. The ex-dividend date of this dividend is Thursday, December 19th. This represents a yield of 2.21%. This is a boost from International Biotechnology’s previous dividend of $14.50. International Biotechnology’s payout ratio is presently 6,041.67%.

About International Biotechnology

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.